Alkermes plc Book/Share
What is the Book/Share of Alkermes plc?
The Book/Share of Alkermes plc is 7.87
What is the definition of Book/Share?
Book value per share is a company’s assets minus liabilities divided by the number of shares outstanding.
mrq (most recent quarter)
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Book/Share of companies in the Health Care sector on NASDAQ compared to Alkermes plc
What does Alkermes plc do?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Companies with book/share similar to Alkermes plc
- Ingevity Corp has Book/Share of 7.86
- Cognex has Book/Share of 7.86
- Aryzta Ag has Book/Share of 7.86
- GrainCorp has Book/Share of 7.86
- Getech Plc has Book/Share of 7.86
- BCC Fuba India has Book/Share of 7.86
- Alkermes plc has Book/Share of 7.87
- EO2 has Book/Share of 7.88
- CIMC Vehicle () Co has Book/Share of 7.88
- Gabelli Multimedia Trust Inc has Book/Share of 7.88
- Rua Life Sciences Plc has Book/Share of 7.89
- Orapi SA has Book/Share of 7.89
- Sierra Wireless Inc has Book/Share of 7.89